CPSI Announces Fourth Quarter and Year-End 2020 Results
Company Launches Transformation Initiative with Goal of $80 million in Adjusted EBITDA in 2024; Targets Three-Year Average Organic Recurring Revenue...
News
Hepion Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference
EDISON, NJ / ACCESSWIRE / February 9, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)("Hepion"), a clinical stage biopharmaceutical company focused on...
Asia Green Biotechnology Corp. Expands Technology Development Relationship with Pathway Rx Inc. and Swysh Inc. with Agreement to Undertake Initial Toxicity Testing for Migraine Study
CALGARY, AB / ACCESSWIRE / February 9, 2021 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased...
Core One Labs Announces Adding Video Conference Capabilities to Teleconference Call Scheduled for February 10, 2021 1:30 p.m. PST/4:30 p.m. EST
VANCOUVER, BC / ACCESSWIRE / February 9, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt::LD62) (WKN: A2P8K3) (the "Company") is...
AirTank Logs Record Business Despite Pandemic
AirTank Experiences Rapid Growth In Client Roster, Expects More to Come PETERBOROUGH, N.H.--(BUSINESS WIRE)--AirTank, a full-service eCommerce consultancy, announced a...
Aerami Therapeutics Signs License Agreement with Hangzhou Chance Pharmaceuticals Co. Ltd. for Aerami’s PAH (pulmonary arterial hypertension) Drug Device Combination in China
DURHAM, N.C., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Aerami Therapeutics, Inc. (“Aerami” or the “Company”) a clinical stage biopharmaceutical company...
Adagene Inc. Announces Pricing of Initial Public Offering
SAN FRANCISCO, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene" or the "Company") (Nasdaq: ADAG), a platform-driven, clinical-stage...
CohBar to Present at the BIO CEO & Investor Digital Conference
MENLO PARK, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Arch Oncology to Collaborate with Merck on Phase 1/2 Clinical Trial of Anti-CD47 Antibody AO-176 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Select Solid Tumors
With Encouraging Safety and Anti-tumor Activity for AO-176 Monotherapy in Phase 1 Trial, Advancing AO-176 in Combination with Anti-PD-1BRISBANE, Calif....
Sharps Compliance Announces Appointment of Pat Mulloy, Veteran CEO of Long-Term and Senior Care Businesses, to Board of Directors
HOUSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national...
Resonant Provides Preliminary Full Year 2020 Financial Results, Revenues Increase Over 330% to a Record $3.2 Million
AUSTIN, Texas, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter intellectual...
Agenus Announces New Responses for AGEN1181
6 total confirmed objective clinical responses in colon, ovarian, and endometrial cancersNo complement-mediated toxicities reportedLEXINGTON, Mass., Feb. 09, 2021 (GLOBE...
Oncology Pharma Renews Licensing Agreement With Ribera Solutions LLC for Its Connect2Med Clinical Trials Platform
San Francisco, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc. (OTC: ONPH) is pleased to announce...
Milestone Scientific Continues Expansion of Distributor Network for Dental Instrument in the US; Adds Two Additional Independent Distributors Covering Atlanta and Tennessee
Adds four independent U.S. distributors in under one month ROSELAND, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc....
NIH Sponsored Study at Stanford University School of Medicine to Utilize Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay to Evaluate Immune Responses in Pediatric Patients with COVID-19
Researchers Seek Insight into Development and Progression of Multisystem Inflammatory Syndrome in Children Study Exemplifies Increasing Use of CyTOF Technology...
Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
NXT-ID Reduces Term Debt by $5.0 Million
Oxford, Connecticut, Feb. 09, 2021 (GLOBE NEWSWIRE) -- NXT-ID, Inc. (“NXTD” or the “Company”) (NASDAQ: NXTD), a provider of healthcare...
THC Therapeutics Has Begun the Process of Acquiring A Significant Amount of Physical Silver Bullion
The company has leveraged the Founder & Chairman’s network to acquire physical silver at a very low premium above spot...
Better Choice Announces $2.0 Million Stock Repurchase Program
NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”), an animal health and wellness...
OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules
GAITHERSBURG, Md., Feb. 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power...